Assays for measuring nucleic acids
US-2024226890-A1 · Jul 11, 2024 · US
US9926592B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9926592-B2 |
| Application number | US-201214357874-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 14, 2012 |
| Priority date | Nov 14, 2011 |
| Publication date | Mar 27, 2018 |
| Grant date | Mar 27, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A category of γPNA miniprobes and chimeric γPNA probes is especially useful for detecting RNA and telomeric DNA in a cell sample. In particular, the probes can be used to deliver fluorescent dyes to the telomeres, allowing direct visualization of telomeres in cells.
Opening claim text (preview).
What is claimed is: 1. A kit for detecting a telomeric DNA in a cell sample, comprising (A) a receptacle that contains a mini-PEG modified γPNA miniprobe that hybridizes with the telomeric DNA, and (B) a receptacle that contains a diluent suitable for hybridization, wherein the mini-PEG modified γPNA miniprobe comprises at least one PNA monomer that is a mini-PEG modified γPNA monomer having the structure wherein Base is a nucleobase. 2. The kit according to claim 1 , wherein the mini-PEG modified γPNA miniprobe consists of six, nine or twelve PNA monomers. 3. The kit according to claim 1 , wherein the mini-PEG modified γPNA miniprobe comprises at least one fluorescent dye as a detectable label. 4. The kit according to claim 3 , wherein the fluorescent dye is selected from the group consisting of Cy3, Cy3B, Cy3.5, Cy5, Cy5.5, Cy7, coumarin, acridine derivatives, eosin derivatives and fluorescein. 5. The kit according to claim 3 , wherein the detectable label is attached to a N-terminal or a C-terminal PNA monomer or a N-terminal or a C-terminal γPNA monomer of the mini-PEG modified γPNA miniprobe. 6. The kit according to claim 3 , wherein the detectable label is attached to an internal PNA monomer or an internal γPNA monomer of the mini-PEG modified γPNA miniprobe. 7. The kit according to claim 3 , wherein the detectable label is attached to a uracil or a cytosine nucleobase of a PNA monomer. 8. The kit according to claim 6 , wherein the detectable label is attached to a γ-carbon of the γPNA monomer. 9. The kit according to claim 8 , wherein the detectable label is attached to the γ-carbon of the γPNA monomer via a linker CH 2 —(O—CH 2 —CH 2 ) n —X, wherein X is selected from the group consisting of —NH 2 —, —CH═CH—, —COOH and —N 3 and n is an integer from 1 to 10. 10. The kit according to claim 1 , wherein the mini-PEG modified γPNA miniprobe comprises two fluorescent dyes. 11. The kit according to claim 1 , wherein the nucleobase sequence of the mini-PEG modified γPNA miniprobe consists of: (A) CCCTAA (nucleobases 13-18 of SEQ ID NO: 2), wherein at least one C is replaced with a G-clamp nucleobase; (B) CCCTAACCC (nucleobases 10-18 of SEQ ID NO: 2); or (C) CCCTAACCCTAA (nucleobases 7-18 of SEQ ID NO: 2). 12. A chimeric mini-PEG modified γPNA miniprobe, comprising: (i) at least one PNA monomer that is a mini-PEG modified γPNA monomer having the structure wherein Base is a nucleobase; (ii) a first, right-handed, domain comprising right-handed PNA monomers, and (iii) a second, left-handed, domain comprising left-handed PNA monomers, wherein the first and second domains are attached to each other end-to-end, optionally via a linker. 13. The chimeric mini-PEG modified γPNA miniprobe according to claim 12 , wherein (A) the first domain comprises from 4 to 10 right-handed PNA monomers; and (B) the second domain comprises from 4 to 7 left handed PNA monomers. 14. The chimeric mini-PEG modified γPNA miniprobe according to claim 12 , wherein the sequence of the first domain is complementary to a telomeric DNA and the second domain does not hybridize with the telomeric DNA. 15. The chimeric mini-PEG modified γPNA miniprobe according to claim 14 , wherein the first domain comprises nine right-handed γPNA monomers and the second domain comprises six left-handed γPNA monomers. 16. The chimeric mini-PEG modified γPNA miniprobe of claim 12 , further comprising at least one detectable label covalently attached to the first domain or the second domain. 17. The chimeric mini-PEG modified γPNA miniprobe of claim 12 , wherein the first domain is attached to the second domain via a linker. 18. The chimeric mini-PEG modified γPNA miniprobe of claim 12 , further comprising at least one detectable label covalently attached to the first domain or the second domain, wherein the first domain is attached to the second domain via a linker. 19. A mini-PEG modified γPNA miniprobe comprising at least one PNA monomer that is a mini-PEG modified γPNA monomer having structure: wherein Base is a nucleobase; wherein the nucleobase sequence of the miniprobe consists of: (A) CCCTAA (nucleobases 18-13 of SEQ ID NO: 2), wherein at least one C is replaced with a G-clamp nucleobase; (B) CCCTAACCC (nucleobases 18-10 of SEQ ID NO: 2); or (C) CCCTAACCCTAA (nucleobases 7-18 of SEQ ID NO: 2). 20. The γPNA miniprobe according to claim 19 , wherein the miniprobe comprises at least one detectable label. 21. The γPNA miniprobe according to claim 19 , comprising two or more of said mini-PEG modified γPNA monomers. 22. The γPNA miniprobe according to claim 19 , wherein all PNA monomers of the miniprobe are said mini-PEG modified γPNA monomers. 23. The γ-RNA miniprobe according to claim 19 , wherein at least one mini-PEG modified γPNA monomer comprises a fluorophore.
Peptide nucleic acid, PNA · CPC title
Nucleic acid detection involving sensors · CPC title
Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title
incorporating a peptide nucleic acid · CPC title
with fluorescent label · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.